The Bipolar Disorders Program is a superspecialized (third-line) consultation and treatment service for adults aged 18 to 65 who suffer from refractory bipolar disorders.

The Mood, Anxiety and Impulsivity Disorders Program at the Douglas Institute provides care to people aged 18 to 65 years with a mood disorder such as Bipolar disorders or Depressive and suicide disorders.

Douglas Hospital was founded in 1881 by Alfred Perry and a group of Protestant clergy and Montréal citizens.

As a clinician, Johanne Renaud holds the title of medical chief for the youth section of the Douglas Institute’s Depressive Disorders Program.

Aurélie Labbe is a biostatistician who specializes in statistical genetics and genetic epidemiology.

Naguib Mechawar identifies the neurochemical and neuroanatomical properties of major depression and suicidal behaviors in the brain.

Gustavo Turecki investigates the neurobiology of suicide, focusing on the role of genetic risk factors.

Serge Beaulieu studies neurobiological responses to antidepressant and mood stabilizer treatment in bipolar disorders.

A major Douglas-led project as been awarded a Brain Canada grant. 

The arrival of a state-of-the-art magnetic resonance imaging (MRI) scanner marks an important step in the construction of the future Brain Imaging Centre at the Douglas Mental Health University Institute.